senescence-associated secretory phenotype SASP
Selected indexed studies
- The senescence-associated secretory phenotype and its physiological and pathological implications. (Nat Rev Mol Cell Biol, 2024) [PMID:38654098]
- The roles and mechanisms of senescence-associated secretory phenotype (SASP): can it be controlled by senolysis? (Inflamm Regen, 2022) [PMID:35365245]
- Inflammation-driven senescence-associated secretory phenotype in cancer-associated fibroblasts enhances peritoneal dissemination. (Cell Rep, 2021) [PMID:33626356]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- ACSS2 drives senescence-associated secretory phenotype by limiting purine biosynthesis through PAICS acetylation. (2025) pubmed
- The senescence-associated secretory phenotype and its physiological and pathological implications. (2024) pubmed
- The roles and mechanisms of senescence-associated secretory phenotype (SASP): can it be controlled by senolysis? (2022) pubmed
- Inflammation-driven senescence-associated secretory phenotype in cancer-associated fibroblasts enhances peritoneal dissemination. (2021) pubmed
- Iron accumulation drives fibrosis, senescence and the senescence-associated secretory phenotype. (2023) pubmed
- Senescence-associated secretory phenotype (SASP) and uterine fibroids: Association with PD-L1 activation and collagen deposition. (2024) pubmed
- NLRP1 inflammasome promotes senescence and senescence-associated secretory phenotype. (2024) pubmed
- The controversial role of senescence-associated secretory phenotype (SASP) in cancer therapy. (2025) pubmed
- Branched-Chain Amino Acid Accumulation Fuels the Senescence-Associated Secretory Phenotype. (2024) pubmed
- EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillance. (2023) pubmed